Published in Biochim Biophys Acta on January 17, 2017
Pathogen recognition and innate immunity. Cell (2006) 44.14
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis (2015) 40.89
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 37.15
Toll-like receptor signalling. Nat Rev Immunol (2004) 34.74
Lipopolysaccharide endotoxins. Annu Rev Biochem (2001) 18.88
Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol (1999) 16.86
Yersinia pestis--etiologic agent of plague. Clin Microbiol Rev (1997) 14.63
Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity (1999) 11.64
The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature (2009) 8.99
Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem (2007) 8.60
Innate immunity. N Engl J Med (2000) 7.03
Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell (2007) 6.84
Biochemistry of endotoxins. Annu Rev Biochem (1990) 6.75
Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev Biochem (2006) 5.41
LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol (2005) 5.25
The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science (2007) 4.90
Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann N Y Acad Sci (2007) 4.20
Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science (2007) 4.01
Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science (1999) 3.98
Membrane lipid homeostasis in bacteria. Nat Rev Microbiol (2008) 3.88
Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol (2002) 3.56
Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J (1991) 3.41
Structures of the toll-like receptor family and its ligand complexes. Immunity (2008) 3.36
Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation. Proc Natl Acad Sci U S A (2000) 3.03
A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. J Clin Invest (1996) 2.94
Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect (2002) 2.90
Coping with cold: the genome of the versatile marine Antarctica bacterium Pseudoalteromonas haloplanktis TAC125. Genome Res (2005) 2.89
Transfer of palmitate from phospholipids to lipid A in outer membranes of gram-negative bacteria. EMBO J (2000) 2.64
Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology. Proc Natl Acad Sci U S A (2013) 2.45
Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-{kappa}B activation but does not contribute to interferon regulatory factor 3 activation. J Biol Chem (2005) 2.41
Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant. PLoS One (2011) 2.39
Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium. J Biol Chem (1982) 2.33
Variation in lipid A structure in the pathogenic yersiniae. Mol Microbiol (2004) 2.28
Diversity of endotoxin and its impact on pathogenesis. J Endotoxin Res (2006) 2.24
Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors. Infect Immun (2006) 2.18
Function of the Escherichia coli msbB gene, a multicopy suppressor of htrB knockouts, in the acylation of lipid A. Acylation by MsbB follows laurate incorporation by HtrB. J Biol Chem (1997) 2.17
TLR-based immune adjuvants. Vaccine (2010) 2.10
Bacterial endotoxins: extraordinary lipids that activate eucaryotic signal transduction. J Bacteriol (1993) 2.09
LPS remodeling is an evolved survival strategy for bacteria. Proc Natl Acad Sci U S A (2012) 2.05
Novel modification of lipid A of Francisella tularensis. Infect Immun (2004) 1.91
Salmonella typhimurium outer membrane remodeling: role in resistance to host innate immunity. Microbes Infect (2001) 1.91
Biosynthesis and export of bacterial lipopolysaccharides. Annu Rev Biochem (2014) 1.90
Identification and analysis of a lipopolysaccharide in cell walls of the blue-green alga Anacystis nidulans. Arch Mikrobiol (1970) 1.89
Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature. Infect Immun (2002) 1.88
Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis. Nat Rev Microbiol (2013) 1.88
Amino acid addition to Vibrio cholerae LPS establishes a link between surface remodeling in gram-positive and gram-negative bacteria. Proc Natl Acad Sci U S A (2012) 1.83
Oxygen requirement for the biosynthesis of the S-2-hydroxymyristate moiety in Salmonella typhimurium lipid A. Function of LpxO, A new Fe2+/alpha-ketoglutarate-dependent dioxygenase homologue. J Biol Chem (2000) 1.76
Biosynthesis of lipid A in Escherichia coli. Acyl carrier protein-dependent incorporation of laurate and myristate. J Biol Chem (1990) 1.69
Regulatory roles for MD-2 and TLR4 in ligand-induced receptor clustering. J Immunol (2006) 1.69
Structural biology of the Toll-like receptor family. Annu Rev Biochem (2011) 1.66
The lipopolysaccharide transport system of Gram-negative bacteria. Biochim Biophys Acta (2009) 1.58
Lipopolysaccharide heterogeneity: innate host responses to bacterial modification of lipid a structure. J Dent Res (2005) 1.53
Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo. J Exp Med (1990) 1.50
Pulmonary and hepatic gene expression following cecal ligation and puncture: monophosphoryl lipid A prophylaxis attenuates sepsis-induced cytokine and chemokine expression and neutrophil infiltration. Infect Immun (1998) 1.49
Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. J Immunol (2001) 1.49
Porphyromonas gingivalis lipopolysaccharide lipid A heterogeneity: differential activities of tetra- and penta-acylated lipid A structures on E-selectin expression and TLR4 recognition. Cell Microbiol (2006) 1.48
Bacterial modification of LPS and resistance to antimicrobial peptides. J Endotoxin Res (2001) 1.47
Structure and biosynthesis of free lipid A molecules that replace lipopolysaccharide in Francisella tularensis subsp. novicida. Biochemistry (2006) 1.47
Modulating the innate immune response by combinatorial engineering of endotoxin. Proc Natl Acad Sci U S A (2013) 1.45
Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia (2008) 1.44
Outer membrane permeability barrier in Escherichia coli mutants that are defective in the late acyltransferases of lipid A biosynthesis. Antimicrob Agents Chemother (1999) 1.43
Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: genetic and evolutionary studies. J Endotoxin Res (2001) 1.39
An outer membrane enzyme encoded by Salmonella typhimurium lpxR that removes the 3'-acyloxyacyl moiety of lipid A. J Biol Chem (2006) 1.39
Structural heterogeneity and environmentally regulated remodeling of Francisella tularensis subspecies novicida lipid A characterized by tandem mass spectrometry. J Am Soc Mass Spectrom (2007) 1.37
TLR4 antagonists for endotoxemia and beyond. Curr Opin Investig Drugs (2005) 1.34
Characterization of late acyltransferase genes of Yersinia pestis and their role in temperature-dependent lipid A variation. J Bacteriol (2006) 1.34
Porphyromonas gingivalis lipopolysaccharide antagonizes Escherichia coli lipopolysaccharide at toll-like receptor 4 in human endothelial cells. Infect Immun (2003) 1.34
Lipid A and immunotherapy. Rev Infect Dis (1984) 1.29
Crystal structure and acyl chain selectivity of Escherichia coli LpxD, the N-acyltransferase of lipid A biosynthesis. Biochemistry (2009) 1.28
Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia. J Infect Dis (2003) 1.23
Comparison of lipopolysaccharides from Agmenellum quadruplicatum to Escherichia coli and Salmonella typhimurium by using thin-layer chromatography. J Bacteriol (1975) 1.22
Dissemination of lipid A deacylases (pagL) among gram-negative bacteria: identification of active-site histidine and serine residues. J Biol Chem (2004) 1.22
The lipid A phosphate position determines differential host Toll-like receptor 4 responses to phylogenetically related symbiotic and pathogenic bacteria. Infect Immun (2010) 1.22
Synthesis of lipopolysaccharide O-antigens by ABC transporter-dependent pathways. Carbohydr Res (2012) 1.19
Acylation of the lipooligosaccharide of Haemophilus influenzae and colonization: an htrB mutation diminishes the colonization of human airway epithelial cells. Infect Immun (2002) 1.19
Tumor regression caused by endotoxins and mycobacterial fractions. J Natl Cancer Inst (1975) 1.17
Porphyromonas gingivalis lipopolysaccharide is poorly recognized by molecular components of innate host defense in a mouse model of early inflammation. Infect Immun (1995) 1.16
Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii. Antimicrob Agents Chemother (2013) 1.14
Humanized TLR4/MD-2 mice reveal LPS recognition differentially impacts susceptibility to Yersinia pestis and Salmonella enterica. PLoS Pathog (2012) 1.13
A Haemophilus influenzae gene that encodes a membrane bound 3-deoxy-D-manno-octulosonic acid (Kdo) kinase. Possible involvement of kdo phosphorylation in bacterial virulence. J Biol Chem (1999) 1.10
Production and properties of cyanobacterial endotoxins. Appl Environ Microbiol (1982) 1.09
Toll-like receptors are part of the innate immune defense system of sponges (demospongiae: Porifera). Mol Biol Evol (2006) 1.09
Deciphering the unusual acylation pattern of Helicobacter pylori lipid A. J Bacteriol (2008) 1.07
Fluorescence polarization in studies of bacterial cytoplasmic membrane fluidity under environmental stress. Prog Biophys Mol Biol (2007) 1.07
Altered linkage of hydroxyacyl chains in lipid A of Campylobacter jejuni reduces TLR4 activation and antimicrobial resistance. J Biol Chem (2010) 1.07
A phase II, double-blind, placebo-controlled, ascending-dose study of Eritoran (E5564), a lipid A antagonist, in patients undergoing cardiac surgery with cardiopulmonary bypass. Anesth Analg (2007) 1.05
Taxonomic studies of predatory bdellovibrios based on 16S rRNA analysis, ribotyping and the hit locus and characterization of isolates from the gut of animals. Syst Appl Microbiol (2001) 1.04
Novel variation of lipid A structures in strains of different Yersinia species. FEBS Lett (2000) 1.02
Molecular structure of endotoxins from Gram-negative marine bacteria: an update. Mar Drugs (2007) 1.00
Enzymatic synthesis of lipid A molecules with four amide-linked acyl chains. LpxA acyltransferases selective for an analog of UDP-N-acetylglucosamine in which an amine replaces the 3"-hydroxyl group. J Biol Chem (2004) 1.00
The role of Pseudomonas lipopolysaccharide in cystic fibrosis airway infection. Subcell Biochem (2010) 0.99
Lipid A structure of Pseudoalteromonas haloplanktis TAC 125: use of electrospray ionization tandem mass spectrometry for the determination of fatty acid distribution. J Mass Spectrom (2002) 0.98
Mass spectrometry advances in lipidomica: collision-induced decomposition of Kdo2-lipid A. Prostaglandins Other Lipid Mediat (2005) 0.97
NMR studies of hexaacylated endotoxin bound to wild-type and F126A mutant MD-2 and MD-2·TLR4 ectodomain complexes. J Biol Chem (2012) 0.96
Structure of compositionally simple lipopolysaccharide from marine synechococcus. J Bacteriol (2009) 0.94
Expression of a Porphyromonas gingivalis lipid A palmitylacyltransferase in Escherichia coli yields a chimeric lipid A with altered ability to stimulate interleukin-8 secretion. Cell Microbiol (2006) 0.93